These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 25076327

  • 1. Biological identification of ampullary adenocarcinomas.
    Relias V, Saif MW.
    JOP; 2014 Jul 28; 15(4):306-7. PubMed ID: 25076327
    [Abstract] [Full Text] [Related]

  • 2. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC.
    Mod Pathol; 2001 Mar 28; 14(3):139-46. PubMed ID: 11266517
    [Abstract] [Full Text] [Related]

  • 3. Survival in ampullary cancer: potential role of different KRAS mutations.
    Valsangkar NP, Ingkakul T, Correa-Gallego C, Mino-Kenudson M, Masia R, Lillemoe KD, Fernández-del Castillo C, Warshaw AL, Liss AS, Thayer SP.
    Surgery; 2015 Feb 28; 157(2):260-8. PubMed ID: 25616942
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
    Franko J, Krasinskas AM, Nikiforova MN, Zarnescu NO, Lee KK, Hughes SJ, Bartlett DL, Zeh HJ, Moser AJ.
    J Gastrointest Surg; 2008 Oct 28; 12(10):1664-72; discussion 1672-3. PubMed ID: 18677542
    [Abstract] [Full Text] [Related]

  • 5. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ, Kim JW, Jung JP, Cho JW, Nam ES, Cho SJ, Kim JS, Park HR, Min SK, Seo J, Min KW, Kim DH, Jeon JY.
    Hum Pathol; 2016 Apr 28; 50():90-100. PubMed ID: 26997442
    [Abstract] [Full Text] [Related]

  • 6. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
    Ebert MP, Hoffmann J, Schneider-Stock R, Kasper HU, Schulz HU, Lippert H, Roessner A, Malfertheiner P.
    Eur J Gastroenterol Hepatol; 1998 Dec 28; 10(12):1025-9. PubMed ID: 9895049
    [Abstract] [Full Text] [Related]

  • 7. Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.
    Schultz NA, Roslind A, Christensen IJ, Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann M, Johansen JS.
    Pancreas; 2012 Jul 28; 41(5):759-66. PubMed ID: 22699145
    [Abstract] [Full Text] [Related]

  • 8. Multiparameter digital image analysis of biliary, ampullary, and pancreatic adenocarcinomas.
    Yeaton P, Kiss R, DePrez C, Salmon I, Pasteels JL, Jones RS, Frierson HF.
    Mod Pathol; 1995 Oct 28; 8(8):843-7. PubMed ID: 8552573
    [Abstract] [Full Text] [Related]

  • 9. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
    McCarthy DM, Hruban RH, Argani P, Howe JR, Conlon KC, Brennan MF, Zahurak M, Wilentz RE, Cameron JL, Yeo CJ, Kern SE, Klimstra DS.
    Mod Pathol; 2003 Mar 28; 16(3):272-8. PubMed ID: 12640108
    [Abstract] [Full Text] [Related]

  • 10. KRAS in pancreatic cancer.
    Agarwal A, Saif MW.
    JOP; 2014 Jul 28; 15(4):303-5. PubMed ID: 25076326
    [Abstract] [Full Text] [Related]

  • 11. Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.
    Deshpande V, Konstantinidis IT, Castillo CF, Hezel AF, Haigis KM, Ting DT, Bardeesy N, Goyal L, Zhu AX, Warshaw AL, Lillemoe KD, Ferrone CR.
    J Gastrointest Surg; 2016 May 28; 20(5):953-9. PubMed ID: 26956004
    [Abstract] [Full Text] [Related]

  • 12. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
    Kwon MJ, Kim JW, Jeon JY, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Min KW, Choe JY, Lee HK.
    Pathol Res Pract; 2017 Apr 28; 213(4):381-388. PubMed ID: 28214200
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
    Mikhitarian K, Pollen M, Zhao Z, Shyr Y, Merchant NB, Parikh A, Revetta F, Washington MK, Vnencak-Jones C, Shi C.
    Mod Pathol; 2014 May 28; 27(5):665-74. PubMed ID: 24186143
    [Abstract] [Full Text] [Related]

  • 14. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC, Kerr SE, Kipp BR, Voss JS, Minot DM, Tu ZJ, Henry MR, Graham RP, Vasmatzis G, Cheville JC, Lazaridis KN, Levy MJ.
    Oncotarget; 2016 Aug 23; 7(34):54526-54536. PubMed ID: 27203738
    [Abstract] [Full Text] [Related]

  • 15. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L, Orbetegli O, Bianchi P, Zerbi A, Di Carlo V, Boland CR, Malesci A.
    Oncogene; 2002 Jun 20; 21(27):4301-6. PubMed ID: 12082617
    [Abstract] [Full Text] [Related]

  • 16. Mutational analysis of the P16-binding domain of cyclin-dependent kinase 4 in tumors in the head region of the pancreas.
    Ceha HM, Clement MJ, Polak MM, Offerhaus GJ, Slebos RJ.
    Pancreas; 1998 Jul 20; 17(1):85-8. PubMed ID: 9667525
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
    Schultz NA, Werner J, Willenbrock H, Roslind A, Giese N, Horn T, Wøjdemann M, Johansen JS.
    Mod Pathol; 2012 Dec 20; 25(12):1609-22. PubMed ID: 22878649
    [Abstract] [Full Text] [Related]

  • 18. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Pancreas; 2008 Mar 20; 36(2):173-7. PubMed ID: 18376309
    [Abstract] [Full Text] [Related]

  • 19. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B, Kimura W, Futakawa N, Muto T, Kubota K, Harihara Y, Takayama T, Makuuchi M.
    Am J Gastroenterol; 1999 Aug 20; 94(8):2128-34. PubMed ID: 10445539
    [Abstract] [Full Text] [Related]

  • 20. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
    Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H.
    Ann Surg; 1991 Dec 20; 214(6):657-62. PubMed ID: 1741644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.